Coronary Disease Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, 'Coronary Disease Global Clinical Trials Review, H1, 2012" provides data on the Coronary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Coronary Disease Global Clinical Trials Review, H1, 2012
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Coronary Disease Global Clinical Trials Review, H1, 2012
Published on June 2012
Report Summary
Coronary Disease Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, 'Coronary Disease Global Clinical Trials Review, H1, 2012" provides data on the Coronary Disease
clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Disease. It includes
an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a
preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing
pertaining to the number of trials for the key drugs for treating Coronary Disease. This report is built using data and information
sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated
disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and
Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Coronary Disease 7
Report Guidance 7
Clinical Trials by Region 8
Coronary Disease Global Clinical Trials Review, H1, 2012 (From Slideshare) Page 1/8
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Coronary Disease 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Coronary Disease Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Merck & Co., Inc. 35
Clinical Trial Overview of Merck & Co., Inc. 35
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
Abbott Laboratories 39
Clinical Trial Overview of Abbott Laboratories 39
F. Hoffmann-La Roche Ltd. 40
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
Pfizer Inc. 42
Clinical Trial Overview of Pfizer Inc. 42
GE Healthcare 43
Clinical Trial Overview of GE Healthcare 43
Genzyme Corporation 44
Clinical Trial Overview of Genzyme Corporation 44
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
TCA Cellular Therapy, LLC 46
Clinical Trial Overview of TCA Cellular Therapy, LLC 46
Clinical Trial Overview of 47
Sanofi 47
Clinical Trial Overview of Sanofi 47
Gilead Sciences, Inc. 48
Clinical Trial Overview of Gilead Sciences, Inc. 48
Acusphere, Inc. 49
Clinical Trial Overview of Acusphere, Inc. 49
Coronary Disease Global Clinical Trials Review, H1, 2012 (From Slideshare) Page 2/8
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Medicines Company 50
Clinical Trial Overview of The Medicines Company 50
Scios Inc. 51
Clinical Trial Overview of Scios Inc. 51
AVI BioPharma Inc. 52
Clinical Trial Overview of AVI BioPharma Inc. 52
CardioDx, Inc. 53
Clinical Trial Overview of CardioDx, Inc. 53
Resverlogix Corp. 54
Clinical Trial Overview of Resverlogix Corp. 54
Eisai Inc. 55
Clinical Trial Overview of Eisai Inc. 55
Clinical Trial Overview of Top Universities / Institutes / Hospitals 56
Deutsches Herzzentrum Munchen 56
Clinical Trial Overview of Deutsches Herzzentrum Munchen 56
University of California, San Francisco 57
Clinical Trial Overview of University of California, San Francisco 57
University of Ottawa Heart Institute 58
Clinical Trial Overview of University of Ottawa Heart Institute 58
The University of Edinburgh 59
Clinical Trial Overview of The University of Edinburgh 59
Seoul National University Hospital 60
Clinical Trial Overview of Seoul National University Hospital 60
William Beaumont Hospitals 61
Clinical Trial Overview of William Beaumont Hospitals 61
Brigham and Women's Hospital 62
Clinical Trial Overview of Brigham and Women's Hospital 62
University of Leipzig 63
Clinical Trial Overview of University of Leipzig 63
Assistance Publique - Hopitaux de Paris 64
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 64
Sheba Medical Center 65
Clinical Trial Overview of Sheba Medical Center 65
University of Nebraska 66
Clinical Trial Overview of University of Nebraska 66
Boston University 67
Clinical Trial Overview of Boston University 67
Vanderbilt University 68
Clinical Trial Overview of Vanderbilt University 68
University of Florida 69
Clinical Trial Overview of University of Florida 69
Rigshospitalet 70
Clinical Trial Overview of Rigshospitalet 70
Cedars-Sinai Medical Center 71
Clinical Trial Overview of Cedars-Sinai Medical Center 71
University of Oxford 72
Clinical Trial Overview of University of Oxford 72
Emory University 73
Coronary Disease Global Clinical Trials Review, H1, 2012 (From Slideshare) Page 3/8
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Clinical Trial Overview of Emory University 73
Medical University of Vienna 74
Clinical Trial Overview of Medical University of Vienna 74
Skejby Hospital 75
Clinical Trial Overview of Skejby Hospital 75
Five Key Clinical Profiles 76
Appendix 99
Abbreviations 99
Definitions 100
Research Methodology 101
Secondary Research 101
About GlobalData 102
Contact Us 102
Disclaimer 102
Source 102
List of Tables
Coronary Disease Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Coronary Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Coronary Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Coronary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Coronary Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Coronary Disease Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Coronary Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Coronary Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
Coronary Disease Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Coronary Disease Therapeutics Clinical Trials, G7 Countries, 2012* 17
Coronary Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Coronary Disease Therapeutics Clinical Trials, E7 Countries, 2012* 19
Coronary Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Coronary Disease Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Coronary Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Coronary Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Coronary Disease Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Coronary Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Coronary Disease Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Coronary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 29
Coronary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 31
Coronary Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33
Coronary Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 34
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 35
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 37
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 39
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 40
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 41
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 42
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GE Healthcare, 2012* 43
Coronary Disease Global Clinical Trials Review, H1, 2012 (From Slideshare) Page 4/8
5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012* 44
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 45
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by TCA Cellular Therapy, LLC, 2012* 46
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 47
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012* 48
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Acusphere, Inc., 2012* 49
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines Company, 2012* 50
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Scios Inc., 2012* 51
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AVI BioPharma Inc., 2012* 52
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioDx, Inc., 2012* 53
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Resverlogix Corp., 2012* 54
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 55
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsches Herzzentrum Munchen, 2012* 56
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 57
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2012* 58
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Edinburgh, 2012* 59
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 60
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by William Beaumont Hospitals, 2012* 61
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012* 62
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2012* 63
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 64
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012* 65
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2012* 66
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2012* 67
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 68
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012* 69
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2012* 70
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012* 71
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2012* 72
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 73
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 74
Coronary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Skejby Hospital, 2012* 75
List of Figures
Coronary Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Coronary Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Coronary Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Coronary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Coronary Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Coronary Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Coronary Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14
Coronary Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
Coronary Disease Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Coronary Disease Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Coronary Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Coronary Disease Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Coronary Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Coronary Disease Global Clinical Trials Review, H1, 2012 (From Slideshare) Page 5/8
6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Coronary Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Coronary Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Coronary Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Coronary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 29
Coronary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Coronary Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Coronary Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 34
GlobalData Methodology 101
Coronary Disease Global Clinical Trials Review, H1, 2012 (From Slideshare) Page 6/8
7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Coronary Disease Global Clinical Trials Review, H1, 2012
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 2 500.00 Quantity: _____
Site License--USD 5 000.00 Quantity: _____
Corporate License--USD 7 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Coronary Disease Global Clinical Trials Review, H1, 2012 (From Slideshare) Page 7/8
8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Coronary Disease Global Clinical Trials Review, H1, 2012 (From Slideshare) Page 8/8